查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363092

癌症免疫疗法药物研发发现外包市场规模、份额、趋势分析报告：按药物类型、癌症类型、服务类型、地区和细分市场预测，2023-2030 年

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal antibodies, Immunomodulators), By Cancer Type (Lung, Breast), By Service Type, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 98 Pages | 商品交期: 2-10个工作天内

价格

癌症免疫治疗药物研发外包市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球癌症免疫疗法药物研发发现外包市场预计将达到 25 亿美元。

预计2023年至2030年该市场将以9.8%的年复合成长率扩张。该市场的主要促进因素是全球癌症患病不断上升、製药和生物技术公司对癌症研究的投资增加以及人们对先进癌症治疗的认识不断提高。

在 COVID-19 大流行的早期阶段，癌症免疫疗法药物研发市场的成长陷入停滞。这是由于感染了 COVID-19 的患者大量涌入，需要紧急加护治疗和治疗。此外，供应链中断、防止疫情的旅行限制以及严格的法规正在减缓癌症免疫治疗药物研发市场的发展。然而，製药公司和法规的策略方法可以显着减少这种影响。

市场的其他促进因素包括外包药物研发发现的需求迅速增长，因为与内部研发成本相比，外包药物发现的成本较低，并且可以提供多种好处的税额扣抵。例如，税务机关常见的问题将减少，製药和生物技术公司将能够利用 CRO 有效规划其全球专案。世界各国政府也积极参与并采取措施癌症治疗。例如，2022年4月，印度政府推出了17家癌症治疗医院。这是塔塔信託公司和政府之间的一项联合倡议，旨在创建一个负担得起的癌症治疗网络。

此外，多种新分子和新的免疫治疗方案正在开发用于癌症免疫治疗，包括检查点抑制剂、免疫调节剂、肿瘤浸润淋巴细胞和CAR-T细胞治疗。其他几种药物仍在研发中，以确认抗癌功效。

癌症免疫疗法药物研发外包市场报告亮点

  • 单株抗体领域占市场主导地位，2022年占最大销售份额，达63.0%。这种增长得益于高功效和不断增加的法规核准。
  • 铅筛选和表征领域预计在预测期内将以最快的年复合成长率成长。这是由于越来越多的新的有效方法减少了该领域有效检测所需的时间。
  • 2022 年，肺癌细分市场占收益占有率最大，达 24.5%。这种增加是由于针对这种癌症类型的许多有效免疫疗法的普及。
  • 北美市场占据主导地位，2022 年占 36.2% 的销售份额。这是由于该地区对新技术的需求不断增长以及癌症罹患率不断上升。

目录

第1章调查方法与范围

第2章执行摘要

第3章癌症免疫治疗药物研发外包市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 癌症免疫疗法药物研发外包市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章癌症免疫治疗药物研发外包：药物类型的估计和趋势分析

  • 癌症免疫治疗药物研发外包市场：重点
  • 癌症免疫疗法药物研发外包市场：2022 年和 2030 年趋势和市场占有率分析
  • 单株抗体
  • 免疫调节剂
  • 癌症疫苗和溶瘤病毒疗法
  • 其他的

第5章癌症免疫治疗药物研发外包：服务类型估算与趋势分析

  • 癌症免疫治疗药物研发外包市场：重点
  • 癌症免疫疗法药物研发外包市场：2022 年和 2030 年趋势和市场占有率分析
  • 目标识别与检验
  • 铅筛选与表征
  • 基于细胞的检测

第6章癌症免疫治疗的药物研发外包：癌症类型的估计和趋势分析

  • 癌症免疫治疗药物研发外包市场：重点
  • 癌症免疫疗法药物研发外包市场：2022 年和 2030 年趋势和市场占有率分析
  • 肺
  • 胸部
  • 大肠直肠
  • 黑色素瘤
  • 摄护腺
  • 头部和颈部
  • 子房
  • 胰臟

第7章癌症免疫治疗药物研发外包市场：区域估计和趋势分析

  • 区域展望
  • 按地区分類的癌症免疫疗法药物研发外包市场：要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Explicyte Immuno-Oncology
    • Aquila Biomedical
    • Horizon Discovery Group plc
    • Crown Bioscience Inc.
    • Promega Corporation
    • HD Co. Ltd.
    • BPS Biosciences Inc.
    • Gen script Biotech Corporation
    • Celentyx Ltd.
    • ImmuneXperts SA
    • Personalis
    • STC Biologics
    • Molecular Imaging Inc. (MI Bioresearch Inc.)
    • Covance, Inc.
Product Code: GVR-2-68038-646-2

Cancer Immunotherapy Drug Discovery Outsourcing Market Growth & Trends:

The global cancer immunotherapy drug discovery outsourcing market size is expected to reach USD 2.5 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 9.8% from 2023 to 2030. The main drivers of this market are the increasing prevalence of cancer Worldwide, increasing investment by pharmaceutical and biotechnology companies in cancer research, and the rise in awareness among people for advanced treatment of cancer.

In the early stages of the COVID-19 pandemic, there was a halt in the growth of the cancer immunotherapy drug discovery market. This decrease in cancer immunotherapy drug discovery is due to the influx of a large number of patients that are infected with COVID-19 and require immediate intensive care and treatment. Also, disruptions in the supply chain, travel restrictions to prevent pandemics, and strict regulations have resulted in delays in the cancer immunotherapy drug discovery market. However, this impact will be significantly reduced by adopting strategic methods taken by pharmaceutical companies and regulatory authorities.

Other drivers of the market are the rising demand for outsourcing of drug discovery, which is increasing rapidly due to low cost as compared to in-house R&D costs, and the use of a tax credit that allows several benefits. For instance, reduces problems that are generally encountered with taxation authorities and it allows pharmaceutical and biotechnology companies to plan effectively their global projects with CRO. Also, the governments are actively participating and taking initiatives for cancer treatment. For instance, in April 2022, the government of India launched 17 hospitals for the treatment of cancer. This is a joint initiative taken by Tata trust and the government, to create an affordable cancer care network.

Also, there is the development of various new molecules for cancer immunotherapy and new immunotherapeutic options such as checkpoint inhibitors, immunomodulators, tumor-infiltrating lymphocytes, and CAR-T cell therapy. Several others are still in the pipeline to check their efficacy against cancer.

Cancer Immunotherapy Drug Discovery Outsourcing Market Report Highlights:

  • The monoclonal antibodies segment dominated the market and accounted for the largest revenue share of 63.0% in 2022. This growth is due to high efficacy and a rise in regulatory approvals
  • The lead screening and characterization segment is expected to grow at the fastest CAGR during the forecast period. This is due to a rise in new and effective ways to decrease the time for effective assays in this segment
  • The lung cancer segment accounted for the largest revenue share of 24.5% in 2022. This rise is due to the large number of prevalent effective immunotherapies for this cancer type
  • North America dominated the market and accounted for a revenue share of 36.2% in 2022. This is due to a rise in demand for new technologies and an increasing incidence of cancer in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Service type
    • 1.1.2. Cancer type
    • 1.1.3. Drug type
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service type outlook
    • 2.2.2. Cancer type outlook
    • 2.2.3. Drug type outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cancer Immunotherapy Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Cancer Immunotherapy Drug Discovery Outsourcing: Drug Type Estimates & Trend Analysis

  • 4.1. Cancer Immunotherapy Drug Discovery Outsourcing Market: Key Takeaways
  • 4.2. Cancer Immunotherapy Drug Discovery Outsourcing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Monoclonal Antibodies
    • 4.3.1. Monoclonal antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Immunomodulators
    • 4.4.1. Immunomodulators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Cancer Vaccines and Oncolytic Viral Therapy
    • 4.5.1. Cancer vaccines and oncolytic viral therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cancer Immunotherapy Drug Discovery Outsourcing: Service Type Estimates & Trend Analysis

  • 5.1. Cancer Immunotherapy Drug Discovery Outsourcing Market: Key Takeaways
  • 5.2. Cancer Immunotherapy Drug Discovery Outsourcing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Target Identification and Validation
    • 5.3.1. Target identification and validation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lead Screening and Characterization
    • 5.4.1. Lead screening and characterization market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cell-based Assays
    • 5.5.1. Cell-based assays market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cancer Immunotherapy Drug Discovery Outsourcing: Cancer Type Estimates & Trend Analysis

  • 6.1. Cancer Immunotherapy Drug Discovery Outsourcing Market: Key Takeaways
  • 6.2. Cancer Immunotherapy Drug Discovery Outsourcing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Lung
    • 6.3.1. Lung market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Breast
    • 6.4.1. Breast market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Colorectal
    • 6.5.1. Colorectal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Melanoma
    • 6.6.1. Melanoma market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Prostate
    • 6.7.1. Prostate market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Head & Neck
    • 6.8.1. Head & Neck market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. Ovarian
    • 6.9.1. Ovarian market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.10. Pancreatic
    • 6.10.1. Pancreatic market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cancer Immunotherapy Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Cancer Immunotherapy Drug Discovery Outsourcing Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Explicyte Immuno-Oncology
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Aquila Biomedical
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Horizon Discovery Group plc
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Crown Bioscience Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Promega Corporation
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. HD Co. Ltd.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. BPS Biosciences Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Gen script Biotech Corporation
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Celentyx Ltd.
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. ImmuneXperts SA
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Personalis
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. STC Biologics
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. Molecular Imaging Inc. (MI Bioresearch Inc.)
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. Covance, Inc.
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 3 North America cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 4 North America cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 5 North America cancer immunotherapy drug discovery outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 7 U.S. cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 8 U.S. cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 9 Canada cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 10 Canada cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 11 Canada cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 12 Europe cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 13 Europe cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 14 Europe cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 15 Europe cancer immunotherapy drug discovery outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 17 Germany cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 18 Germany cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 19 UK cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 20 UK cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 21 UK cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 22 France cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 23 France cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 24 France cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 25 Italy cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 26 Italy cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 27 Italy cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 28 Spain cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 29 Spain cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 30 Spain cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 31 Sweden cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 32 Sweden cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 33 Sweden cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 34 Norway cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 35 Norway cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 36 Norway cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 37 Denmark cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 38 Denmark cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 39 Denmark cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cancer immunotherapy drug discovery outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 44 China cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 45 China cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 46 China cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 47 Japan cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 48 Japan cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 49 Japan cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 50 India cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 51 India cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 52 India cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 53 Australia cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 54 Australia cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 55 Australia cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 56 Thailand cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 57 Thailand cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 58 Thailand cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 59 South Korea cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 60 South Korea cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 61 South Korea cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 62 Latin America cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 63 Latin America cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 64 Latin America cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 65 Latin America cancer immunotherapy drug discovery outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 67 Brazil cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 68 Brazil cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 69 Mexico cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 70 Mexico cancer immunotherapy drug discovery outsourcing market, by material, 2018 - 2030 (USD Million)
  • Table 71 Mexico cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 72 Argentina cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 73 Argentina cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 74 Argentina cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cancer immunotherapy drug discovery outsourcing market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa cancer immunotherapy drug discovery outsourcing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 80 South Africa cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 81 South Africa cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 85 UAE cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 86 UAE cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 87 UAE cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)
  • Table 88 Kuwait cancer immunotherapy drug discovery outsourcing market, by drug type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait cancer immunotherapy drug discovery outsourcing market, by service type, 2018 - 2030 (USD Million)
  • Table 90 Kuwait cancer immunotherapy drug discovery outsourcing market, by cancer type, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Cancer immunotherapy drug discovery outsourcing: Market outlook

Fig. 9 Cancer immunotherapy drug discovery outsourcing: Competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 Cancer immunotherapy drug discovery outsourcing market driver impact

Fig. 15 Cancer immunotherapy drug discovery outsourcing market restraint impact

Fig. 16 Cancer immunotherapy drug discovery outsourcing market strategic initiatives analysis

Fig. 17 Cancer immunotherapy drug discovery outsourcing market: Drug type movement analysis

Fig. 18 Cancer immunotherapy drug discovery outsourcing market: drug type outlook and key takeaways

Fig. 19 Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 20 Immunomodulators market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 21 Cancer vaccines and oncolytic viral therapy market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 23 Cancer immunotherapy drug discovery outsourcing market: Service type movement analysis

Fig. 24 Cancer immunotherapy drug discovery outsourcing market: Service type outlook and key takeaways

Fig. 25 Target identification and validation market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 26 Lead screening and characterization market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 27 Cell-based assays market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 28 Cancer immunotherapy drug discovery outsourcing market: Cancer type movement analysis

Fig. 29 Cancer immunotherapy drug discovery outsourcing market: Cancer type outlook and key takeaways

Fig. 30 Lung market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 31 Breast market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 32 Colorectal market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 33 Melanoma market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 34 Prostate market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 35 Head and neck market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 36 Ovarian market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 37 Pancreatic market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 38 Global cancer immunotherapy drug discovery outsourcing market: Regional movement analysis

Fig. 39 Global cancer immunotherapy drug discovery outsourcing market: Regional outlook and key takeaways

Fig. 40 North America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 41 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 42 Canada market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 43 Europe market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 44 UK market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 45 Germany market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 48 Spain market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 49 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 50 Norway market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 53 Japan market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 54 China market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 55 India market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 56 Australia market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 57 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 58 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 59 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 60 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 61 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 62 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 65 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 66 UAE market estimates and forecasts, 2018 - 2030 (USD Million)

Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)